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The phospholipid flippase ATP9A is required for 
the recycling pathway from the endosomes to 
the plasma membrane
ABSTRACT Type IV P-type ATPases (P4-ATPases) are phospholipid flippases that translocate 
phospholipids from the exoplasmic (or luminal) to the cytoplasmic leaflet of lipid bilayers. In 
Saccharomyces cerevisiae, P4-ATPases are localized to specific subcellular compartments and 
play roles in compartment-mediated membrane trafficking; however, roles of mammalian P4-
ATPases in membrane trafficking are poorly understood. We previously reported that ATP9A, 
one of 14 human P4-ATPases, is localized to endosomal compartments and the Golgi com-
plex. In this study, we found that ATP9A is localized to phosphatidylserine (PS)-positive early 
and recycling endosomes, but not late endosomes, in HeLa cells. Depletion of ATP9A delayed 
the recycling of transferrin from endosomes to the plasma membrane, although it did not 
affect the morphology of endosomal structures. Moreover, depletion of ATP9A caused ac-
cumulation of glucose transporter 1 in endosomes, probably by inhibiting their recycling. By 
contrast, depletion of ATP9A affected neither the early/late endosomal transport and degra-
dation of epidermal growth factor (EGF) nor the transport of Shiga toxin B fragment from 
early/recycling endosomes to the Golgi complex. Therefore ATP9A plays a crucial role in re-
cycling from endosomes to the plasma membrane.
INTRODUCTION
Membrane traffic is mediated by vesicular and tubular carriers 
formed at the plasma membrane or organelles by the activities of 
multiple factors, including small GTPases, coat proteins, SNARE 
(soluble NSF [N-ethylmaleimide–sensitive factor] attachment protein 
receptor) proteins, fission proteins such as members of the dynamin 
family, and other accessory proteins. During formation of the vesicu-
lar–tubular carriers and fusion of organelles, dynamic membrane 
shape changes occur. These shape changes are thought to involve 
modification in the composition and distribution of lipids and many 
of the proteins mentioned above (Graham, 2004; Graham and 
Kozlov, 2010; Shin et al., 2012).
The type IV P-type ATPases (P4-ATPases), a subfamily of P-type 
ATPases, have been implicated in flipping of aminophospholipids 
from the exoplasmic (luminal) leaflet to the cytoplasmic leaflet (Tang 
et al., 1996; Pomorski et al., 2003; Daleke, 2007; Coleman et al., 
2009; Zhou and Graham, 2009). Thus P4-ATPases are essential for 
the regulation and generation of trans-bilayer asymmetry of the 
plasma membrane: aminophospholipids, phosphatidylserine (PS), 
and phosphatidylethanolamine (PE) are primarily localized in the 
cytoplasmic leaflet, whereas phosphatidylcholine (PC) and sphingo-
myelin (SM) occur primarily in the exoplasmic leaflet (Op den Kamp, 
1979; Devaux, 1991; Zachowski, 1993; Murate et al., 2015). We re-
cently showed that ATP8B1, ATP8B2, and ATP10A preferentially flip 
PC, but not aminophospholipids (Takatsu et al., 2014; Naito et al., 
2015), whereas ATP11A and ATP11C flip aminophospholipids (Yabas 
et al., 2011; Takatsu et al., 2014; Takada et al., 2015). Moreover, 
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(Muthusamy et al., 2009). P4-ATPases also 
play essential roles in membrane trafficking 
in other organisms, including Caenorhab-
ditis elegans and Arabidopsis thaliana 
(Poulsen et al., 2008; Anne-Francoise et al., 
2009). PS flipped by ATP8A1 is required for 
recruitment of EHD1 to endosomes and for 
endosome-mediated trafficking in COS-1 
cells (Lee et al., 2015). In addition, phospho-
lipid flipping itself, as opposed to the 
flipped phospholipids, is important for vesi-
cle formation in yeast (Takeda et al., 2014). 
Thus the phospholipid-flipping activities of 
P4-ATPases are indispensable for mem-
brane trafficking in eukaryotic cells.
The yeast CDC50 proteins Cdc50p, 
Lem3p, and Crf1p associate with the P4-
TPases Drs2p, Dnf1p/Dnf2p, and Dnf3p, 
respectively (Saito et al., 2004; Furuta et al., 
2007). By contrast, Neo1p P4-ATPase does 
not associate with either Cdc50p or Lem3p 
(Saito et al., 2004). Most of the 14 mamma-
lian P4-ATPases require association with 
CDC50 for their exit from the endoplas-
mic reticulum and subsequent localization 
(Paulusma et al., 2008; Bryde et al., 2010; 
van der Velden et al., 2010; Coleman and 
Molday, 2011; Takatsu et al., 2011). How-
ever, ATP9A and ATP9B, the putative mam-
malian orthologues of Neo1p, do not inter-
act with CDC50 (Takatsu et al., 2011).
Endosomes are multifunctional organ-
elles that regulate membrane transport 
between the plasma membrane and various 
intracellular compartments. After endocy-
tosed cargoes such as soluble proteins, 
membrane proteins, and lipids arrive at early 
endosomes, some (e.g., recycling receptors 
and bulk membrane constituents) are re-
turned to the plasma membrane, whereas 
others (e.g., growth factor receptors and nu-
trients) are transported to late endosomes 
and lysosomes for degradation. Some car-
goes are transported from early endosomes 
to the Golgi complex (Grant and Donaldson, 
2009; Chia and Gleeson, 2011; Johannes 
and Wunder, 2011).
In this study, we analyzed the function 
of ATP9A, which localizes to endosomes 
and the Golgi complex, in the endocytic 
pathway. We found that ATP9A plays an 
important role in recycling of transferrin 
(Tfn) from endosomes to the plasma mem-
brane, but is dispensable for the lysosomal 
degradation of epidermal growth factor 
(EGF) and retrograde transport of Shiga 
toxin B fragment (StxB) from endosomes to the Golgi complex.
RESULTS
ATP9A localizes to the TfnR-positive recycling endosomes
We previously determined the subcellular localization of human P4-
ATPases by transient expression in HeLa cells. Among them, ATP9A 
associated with plasma membrane dynamics, including changes in 
cell shape (Naito et al., 2015; Miyano et al., 2016). Therefore local 
changes in composition of specific phospholipids by P4-ATPases are 
actively involved in the membrane-deformation process.
The five yeast P4-ATPases are all involved in protein transport 
at different stages of the secretory and endocytic pathways 
FIGURE 1: Subcellular localization of ATP9A. HeLa cells stably expressing C-terminally HA-
tagged ATP9A were doubly stained for HA and organelle markers EEA1 (early endosome), TfnR 
(early/recycling endosome), Lamp-1 (late endosome), TGN46 (TGN), and GM130 (cis-Golgi), 
followed by Cy3-conjugated anti-rat and Alexa Fluor 488–conjugated anti-mouse or anti-rabbit 
secondary antibodies. The recombinant EGFP-Lactadherin C2 domain (rEGFP-LactC2) was 
treated with anti-HA antibody after permeabilization of cells with digitonin. Images were 
obtained by confocal microscopy. Insets are enlarged in the right panels. Scale bars: 10 μm.
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the TGN were tubulated upon BFA treat-
ment, but the tubules did not overlap. When 
ATP9A-expressing cells were treated with 
BFA, ATP9A-positive compartments were tu-
bulated and overlapped with either TfnR 
(Figure 2B, inset 1, white arrowheads)- or 
TGN46 (Figure 2B, inset 2, white arrowheads)-
positive tubular structures. Knockdown of 
Rab11a and b also induced tubulation of re-
cycling endosomes (Takahashi et al., 2012). 
Depletion of Rab11a and b in ATP9A-
expressing cells caused tubulation of ATP9A-
positive compartments (Figure 2C). These 
results indicate that ATP9A localizes to the 
recycling endosomes, as well as to early en-
dosomes and the TGN.
Lactadherin C2 domain (LactC2) is a 
specific probe for PS (Gagescu et al., 2000; 
Yeung et al., 2008). Transiently expressed 
enhanced green fluorescent protein (EGFP)-
LactC2 localizes to the endosomal compart-
ments and the plasma membrane (Fairn 
et al., 2011; Uchida et al., 2011). Therefore 
we investigated whether ATP9A colocalizes 
with PS-positive endosomal compartments. 
Because overexpression of EGFP-LactC2 af-
fects endosomal integrity, we exposed cells 
mildly permeabilized with digitonin (Figure 
1C) to recombinant EGFP-LactC2 protein 
(rEGFP-LactC2). ATP9A colocalized exten-
sively with rEGFP-LactC2 (Figure 1C), 
indicating that ATP9A was localized to the 
PS-enriched endosomes. As shown in Sup-
plemental Figure S1A, rEGFP-LactC2 prein-
cubated with PS-liposomes, but not with 
PC- or PI-liposomes, was unable to detect 
subcellular organelles, indicating that the 
purified rEGFP-LactC2 specifically recog-
nized PS-positive organelles. The rEGFP-
LactC2 signals overlapped extensively 
with TfnR, partially with EEA1 and TGN46, 
and rarely with Lamp-1 (Supplemental 
Figure S1B), confirming that PS is enriched 
in the recycling endosomal compartments 
and is present at a lower level in other or-
ganelles (Fairn et al., 2011) in HeLa cells.
Tfn, but not EGF, localizes to PS-positive endosomes all the 
way through the transport process
Tfn and EGF were internalized into cells via clathrin-dependent en-
docytosis and entered early endosomes. At early endosomes, some 
Tfn-TfnR is recycled to the plasma membrane (fast recycling), 
whereas some is transported to the recycling endosomes and recy-
cled back to the plasma membrane (slow recycling). By contrast, 
EGF-EGFR (EGF receptor) is sorted at the early endosomes and 
then delivered to late endosomes and lysosomes for degradation. 
We investigated whether Tfn and EGF pass through the PS-positive 
endosomes during their respective trafficking pathways (Figure 3). 
Cells were incubated with Alexa Fluor 555–conjugated Tfn or EGF 
at 4°C for 60 min, washed to remove unbound Tfn or EGF, and then 
allowed to internalize the surface bound Tfn or EGF at 37°C for 
various time periods. Cells were then fixed, permeabilized, and 
localizes to early/recycling endosomes and the trans-Golgi network 
(TGN; Takatsu et al., 2011). To confirm the localization of ATP9A, we 
established stable cells expressing moderate levels of ATP9A and 
observed ATP9A colocalization with several organelle markers by con-
focal microscopy (Figure 1). ATP9A colocalized with EEA1, transferrin 
receptor (TfnR), and TGN46, which are markers for early endosomes, 
early/recycling endosomes, and the TGN, respectively (Figure 1, A, B, 
and E), but not with Lamp-1 and GM130, which are markers for late 
endosomes and the cis-Golgi, respectively (Figure 1, D and F).
To confirm the recycling endosomal localization of ATP9A, we ob-
served morphological changes of ATP9A-positive compartments fol-
lowing brefeldin A (BFA) treatment of cells stably expressing ATP9A. 
BFA treatment induces tubulation from recycling endosomes and the 
TGN but not from early endosomes (Sonnichsen et al., 2000; Shin 
et al., 2004). As shown in Figure 2A, TfnR-positive endosomes and 
FIGURE 2: Morphological changes in ATP9A-positive compartments following treatment with BFA 
or knockdown of Rab11. (A) HeLa cells or (B) HeLa cells stably expressing ATP9A-HA were treated 
with vehicle (dimethyl sulfoxide) or 5 μg/ml BFA for 15 min. (A) Cells were fixed and doubly stained 
for TfnR and TGN46, followed by Alexa Fluor 488–conjugated anti-mouse and Alexa Fluor 555–
conjugated anti-rabbit secondary antibodies. (B) Cells were triply stained for HA, TfnR, and 
TGN46, followed by Cy3-conjugated anti-rat, Alexa Fluor 488–conjugated anti-mouse, and 
DyLight649-conjugated anti-rabbit secondary antibodies. Insets were enlarged. Scale bar: 10 μm. 
Arrowheads indicate colocalized tubular structures. (C) HeLa cells stably expressing ATP9A-HA 
were treated with siRNAs against LacZ (control) or Rab11a and Rab11b and doubly stained for HA 
and Golgin-245, followed by Cy3-conjugated anti-rat and Alexa Fluor 488–conjugated anti-mouse 
secondary antibodies. Scale bars: 20 μm. Insets were enlarged. Scale bar: 10 μm.
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compartments in cells overexpressing 
ATP9A (Figure 4A, 20 min). This result indi-
cates that overexpression of ATP9A, which 
localizes to early/recycling endosomes, in-
hibits Tfn trafficking, probably by alteration 
of endosomal membrane dynamics. 
Otherwise, it could be an artifact of crowd-
ing membrane proteins in endosomes.
Depletion of ATP9A does not affect 
the endosomal structure
To investigate the role of ATP9A in endo-
some-mediated membrane trafficking, we 
next tried to knock down ATP9A using RNA 
interference (RNAi). To exclude off-target ef-
fects, we designed two different small inter-
fering RNAs (siRNAs), one targeting the cod-
ing region of ATP9A (ATP9A-1) and the other 
targeting the noncoding region (ATP9A-2). 
Efficient depletion of ATP9A mRNA was con-
firmed by quantitative reverse transcription 
PCR (RT-PCR; Figure 5A). Although we were 
unable to raise antibodies capable of de-
tecting endogenous ATP9A, we confirmed 
knockdown of protein expression by ATP9A-1 
siRNA in cells stably expressing hemagglu-
tinin (HA)-tagged ATP9A (Figure 5B).
We then investigated whether deple-
tion of ATP9A would affect the morphol-
ogy of endosomal structures. As shown in 
Figure 5C, knockdown cells did not exhibit any morphological de-
fects in endosomal markers, such as EEA1 for early endosomes (a), 
TfnR for early/recycling endosomes (b), Rab11 for recycling endo-
somes (c), Lamp-1 for late endosomes (d), and TGN46 for TGN (e). 
However, the fluorescent signals of TfnR were higher in ATP9A-
knockdown cells than in control cells (Figure 5C, b–b″), although 
the total TfnR level was comparable to that in control cells (Figure 
5D). Quantitation of TfnR signals (Figure 5E) revealed that the pro-
portion of cells with high fluorescence intensities was higher in 
cells depleted of ATP9A than in control cells. Therefore depletion 
of ATP9A does not affect the integrity and biogenesis of endo-
somes or the integrity of the Golgi complex but may influence the 
trafficking of TfnR.
Depletion of ATP9A inhibits Tfn recycling but not 
internalization
Next we asked whether depletion of ATP9A affects the endocytic/
recycling pathway of Tfn. In these experiments, Tfn-555 was allowed 
to internalize for 30 min at 37°C. Signals of internalized Tfn-555 were 
higher in knockdown cells than in control cells (Figure 5C, f–f″), sug-
gesting that knockdown increased the rate of Tfn endocytosis or in-
hibited Tfn recycling from endosomes to the plasma membrane. To 
investigate the endocytosis and recycling of Tfn more quantitatively, 
we incubated control and knockdown cells with Tfn-555 at 4°C for 
60 min, washed them to remove unbound Tfn-555, and then al-
lowed Tfn-555 to internalize at 37°C for various time periods in the 
presence of unlabeled holo-Tfn (Figure 6, A and B). The amount of 
internalized Tfn-555 at early time points (2.5 min) was not signifi-
cantly affected by knockdown of ATP9A. In control cells, signals of 
internalized Tfn-555 markedly decreased after 20 min incubation at 
37°C, due to recycling of Tfn/TfnR to the plasma membrane. By 
contrast, a significant level of Tfn-555 persisted inside cells depleted 
incubated with rEGFP-LactC2 to visualize PS-positive endosomes. 
Internalized Tfn localized to PS-positive endosomes throughout its 
transport process (Figure 3A). Although internalized EGF localized 
to the PS-positive endosomes at early time points (Figure 3B, 2.5 
and 5 min), it began to be segregated from the PS-positive endo-
somes at 10 min and was completely segregated at later time points 
(Figure 3B, 20 and 60 min). Thus EGF was probably sorted and de-
livered to the PS-poor late endosomes. By contrast, internalized Tfn 
passed through the PS-positive endosomes throughout the trans-
port process, supporting a previous report that PS is required for Tfn 
trafficking (Lee et al., 2015).
Overexpression of ATP9A, but not ATP9B, inhibits the Tfn 
recycling pathway
In yeast, all five P4-ATPases are involved in the membrane traffick-
ing, and some of them genetically interact with clathrin and the 
small GTPase Arf, which play major roles in vesicular transport 
(Chen et al., 1999). Therefore we hypothesized that ATP9A may be 
involved in vesicular transport at the early/recycling endosomes. 
To test this idea, we transiently overexpressed ATP9A and ATP9B, 
which do not localize to endosomes but instead exclusively local-
ize to the Golgi complex (Takatsu et al., 2011), and then monitored 
the endocytosis and recycling of Tfn (Figure 4). We incubated the 
cells with Alexa Fluor 555–conjugated Tfn (Tfn-555) at 4°C for 
60 min, washed them to remove unbound Tfn, and then allowed 
Tfn to internalize at 37°C for the indicated time periods in the 
presence of holo-Tfn. Internalization of Tfn was not affected in 
ATP9A- or ATP9B-expressing cells (Figure 4, A and B, 5 min). After 
a 20 min incubation at 37°C, despite the fact that most internalized 
Tfn was recycled and the intracellular Tfn signal had substantially 
decreased in nontransfected or ATP9B-overexpressing cells 
(Figure 4B), the internalized Tfn had accumulated at endosomal 
FIGURE 3: Tfn, but not EGF, passes through the PS-positive compartments throughout its 
trafficking process. HeLa cells were serum starved for 3 h and then incubated at 4°C for 50 min 
with Alexa Fluor 555–conjugated Tfn or EGF. Cells were washed and chased at 37°C for the 
indicated times, fixed, and mildly permeabilized with digitonin. The cells were then incubated 
with rEGFP-LactC2, washed, and fixed again before mounting. Scale bars: 20 μm.
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and observed by confocal microscopy. Signals of internalized Tfn-
555 partially overlapped with EEA1 but not with Lamp-1, indicating 
that the internalized Tfn was not missorted to late endosomes 
(Figure 6D).
We also examined Tfn recycling in ATP9A-knockout cells estab-
lished using the clustered regularly interspaced short palindromic 
repeats (CRISPR)/Cas9 system (Supplemental Figure S3). Consistent 
with the result of Figure 6A, recycling of Tfn, but not endocytosis, 
was delayed in two independent ATP9A-knockout clones (Supple-
mental Figure S4).
Depletion of ATP9A increases intracellular glucose 
transporter 1 (GLUT1)
We next investigated whether depletion of ATP9A would affect re-
cycling of other cargo proteins. GLUT1 cycles between endosomes 
and the plasma membrane (Bridgewater et al., 2012; Steinberg 
et al., 2013; De Franceschi et al., 2015). In control cells, GLUT1 
mainly localized to the plasma membrane and rarely to intracellular 
compartments (Figure 7A). By contrast, intracellular punctate stain-
ing of GLUT1 appeared in cells depleted of ATP9A (Figure 7A). The 
punctate structures colocalized with EEA1, TfnR, and Vps35 (a 
component of retromer complex), but not with Lamp-1, indicating 
that localization of GLUT1 in steady state was shifted to early and 
recycling endosomes from the plasma membrane in ATP9A-knock-
down cells. Counting of cells in which GLUT1 localized to the plasma 
membrane, plasma membrane and endosomes, or endosomes 
(Figure 7B) revealed that endosomal localization of GLUT1 was sub-
stantially increased in cells depleted of ATP9A. We also confirmed 
that GLUT1 localization was shifted from the plasma membrane to 
endosomes in ATP9A-knockout cells (Figure 7D). Thus, in cells de-
pleted of ATP9A, GLUT1 accumulated in endosomes, probably due 
to the delay of recycling from endosomes to the plasma membrane. 
Therefore ATP9A is required for the recycling of TfnR and GLUT1 
from endosomes to the plasma membrane.
Depletion of ATP9A does not inhibit trafficking of StxB 
and EGF
We next examined the effects of the ATP9A knockdown on lyso-
somal transport of endocytosed EGF, which passes through early 
and late endosomes. After serum starvation, control and knockdown 
cells were incubated with Alexa Fluor 488–conjugated EGF (EGF-
488) at 4°C for 60 min, washed to remove unbound EGF-488, and 
then allowed to internalize EGF-488 at 37°C for various time periods. 
The internalized EGF-488 colocalized extensively with the early en-
dosomal marker EEA1 at early time points (Figure 8, 5 and 10 min), 
and a significant pool of EGF was segregated from early endosomes 
at later time points. After 120 min, the EGF-488 signal dramatically 
decreased due to lysosomal degradation. Endocytosis and the deg-
radation of EGF was not significantly affected over the course of in-
cubation in cells depleted of ATP9A (Figure 8A). We calculated the 
ratios of EGF-488 fluorescence intensity between ATP9A knockdown 
cells and control cells at each time point (Figure 8B).
We next examined the retrograde transport of StxB, which tra-
verses through early/recycling endosomes en route to the TGN 
(Mallard et al., 1998; Shin et al., 2004) and endoplasmic reticulum. 
Cells treated with siRNAs against either LacZ or ATP9A were incu-
bated for 60 min at 4°C with StxB. After cells were washed with 
phosphate-buffered saline (PBS), internalization was allowed to pro-
ceed at 37°C for the indicated time periods in the absence of StxB. 
Immunofluorescence and subsequent semiquantitative analysis re-
vealed no significant differences between control and ATP9A-
knockdown cells over the course of incubation (Figure 9, A and B). 
of ATP9A. After 30 min, Tfn-555 disappeared almost completely 
from control cells, whereas some Tfn-555 was still retained within the 
knockdown cells. Thus the endocytosis of Tfn was not affected, but 
the recycling of Tfn was considerably delayed (but not completely 
blocked) by the depletion of ATP9A. We calculated the ratios of 
fluorescence intensity of Tfn-555 between ATP9A-knockdown cells 
and control cells at each time point (Figure 6B).
To examine the recycling of Tfn more quantitatively in single 
cells, we incubated cells with Tfn-555 at 37°C for 30 min, washed 
them to remove unbound Tfn-555, and then incubated them at 
37°C in the absence of labeled Tfn. The reduction in the Tfn-555 
signal due to recycling was recorded in single cells by time-lapse 
microscopy (images acquired every 2 min), and the intracellular fluo-
rescence intensity of Tfn-555 was quantitated (Figure 6C). Recycling 
of Tfn was delayed in cells depleted of ATP9A (Figure 6C; raw data, 
Supplemental Figure S2). Taken together, these observations 
indicate that ATP9A is required for efficient recycling of Tfn from 
endosomes to the plasma membrane but dispensable for the endo-
cytosis of Tfn.
Next we asked whether the internalized Tfn was missorted to 
late endosomes in ATP9A-knockdown cells. To this end, cells were 
stained with anti–Lamp-1 antibody at the 20 min points in Figure 6A 
FIGURE 4: Overexpression of ATP9A affects Tfn trafficking. HeLa 
cells were transiently transfected with expression vector encoding 
HA-tagged ATP9A (A) or ATP9B (B), serum starved for 3 h, and then 
incubated at 4°C for 50 min with Alexa Fluor 488–conjugated Tfn. 
Cells were washed and chased at 37°C for 5 min and 20 min in the 
absence of the labeled Tfn. Cells were fixed and incubated with 
anti-HA antibody followed by Cy3-conjugated anti-rat secondary 
antibody (asterisks: overexpressing cells). Scale bars: 20 μm.
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Nakai et al., 2013). ATP9A seems to be lo-
calized to the membrane domain in which 
recycling cargoes accumulate, and thus may 
play a role in the formation of plasma mem-
brane–destined vesicles or tubules from en-
dosomes. Depletion of ATP9A did not abro-
gate the Tfn recycling but delayed the 
recycling rate. Thus we cannot exclude a 
possibility of the functional redundancy in 
the P4-ATPase family. Despite the fact that 
Tfn recycling was inhibited by the overex-
pression of ATP9A, the recycling was not af-
fected by the overexpression of ATP9B, a 
close homologue of ATP9A (Figure 4), sug-
gesting that ATP9B may not be involved in 
the recycling pathway.
In yeast, PS flipping by Drs2p enhances 
membrane curvature, and the resultant neg-
ative charge is required for the function of 
Gcs1p, which is crucial for protein transport 
between the TGN and endosomes (Xu 
et al., 2013; Hankins et al., 2015). In COS-1 
cells, PS in the cytoplasmic leaflet of recy-
cling endosomes is required for recruitment 
of evectin-2, which plays a role in cholera 
toxin transport from the endosomes to the 
Golgi (Uchida et al., 2011). Therefore flip-
ping of PS and the presence of PS in the 
cytoplasmic leaflet is crucial for endosome-
mediated protein transport. Although we 
do not know whether ATP9A flips PS, or 
whether its flippase activity is required for 
the recycling pathway, it is tempting to 
speculate that ATP9A regulates PS translo-
cation in endosomes because 1) ATP9A localizes to LactC2-positive 
endosomes; 2) internalized Tfn localizes to LactC2-positive endo-
somes during the course of endocytosis and recycling, and ATP9A is 
required for Tfn recycling; and 3) internalized EGF is localized to the 
LactC2-positive endosomes only at early time points but segregates 
from these compartments at later time points. On one hand, Takeda 
et al. (2014) proposed that flippase-dependent vesicle formation is 
mediated by phospholipid flipping, rather than by the flipped phos-
pholipids. Accordingly, it is not clear whether flippase activity itself 
(causing lipid composition changes between lipid bilayers), flipped 
PS (causing recruitment of effector proteins, such as evectin-2), or 
both are required for the membrane-trafficking pathway. In any 
case, we believe that the flippase activity of ATP9A is involved in the 
formation of transport vesicles or tubules from a specialized mem-
brane domain in endosomes, although we have not yet identified its 
lipid substrate.
ATP8A1 is localized to the PS-positive recycling endosomes and 
is involved in the membrane traffic through endosomes in COS-1 
cells (Lee et al., 2015). In HeLa cells, however, ATP8A1 localizes to 
late endosomes, but not early/recycling endosomes (Takatsu et al., 
2011), even in cells stably expressing moderate levels of the protein 
(Supplemental Figure S5A). Moreover, the ATP8A1 mRNA level in 
HeLa cells is much lower than in other cell types, whereas the ATP9A 
mRNA level is comparable (Supplemental Figure S5B). Therefore 
ATP8A1 may not play a crucial role in the recycling pathway in HeLa 
cells.
We observed no significant change in the distribution of cyto-
plasmic PS, which is detected with EGFP-LactC2, in cells depleted 
Therefore it is unlikely that ATP9A is required for retrograde trans-
port of StxB from early/recycling endosomes to the Golgi complex. 
Together these observations suggest that ATP9A is not required 
for the late endosomal/lysosomal transport of EGF from early 
endosomes or the retrograde transport of StxB from early/recycling 
endosomes.
DISCUSSION
Here we demonstrated that ATP9A, a member of the P4-ATPase 
family, is localized to the early/recycling endosomes and the TGN 
and is required for efficient recycling of TfnR and GLUT1 from endo-
somes to the plasma membrane. Although depletion of ATP9A did 
not affect the integrity or biogenesis of endosomal compartments, 
it inhibited efficient Tfn recycling from endosomal compartments to 
the plasma membrane but not StxB transport from endosomes to 
the Golgi complex. Thus ATP9A might be localized to a specialized 
membrane domain of early/recycling endosomes, where it is in-
volved in recycling to the plasma membrane but not retrograde 
transport to the Golgi complex. In addition, internalized Tfn and 
accumulated intracellular GLUT1 were not missorted to late endo-
somes in ATP9A-depleted cells, suggesting that ATP9A may not be 
involved in cargo sorting at endosomes. We previously showed that, 
although a pair of the small GTPases Arf1/Arf4 and Arf1/Arf3 are 
redundantly required for the integrity of recycling endosomes, 
the former pair is required for StxB transport from endosomes to the 
TGN, whereas the latter is required for Tfn recycling from endo-
somes to the plasma membrane, indicating the presence of a 
specialized membrane domain in endosomes (Kondo et al., 2012; 
FIGURE 5: Depletion of ATP9A does not affect the distribution of organelles. (A) HeLa cells 
were transfected with siRNAs against LacZ (control), ATP9A-1, or ATP9A-2, and total RNAs were 
isolated from the cells, and RT-qPCR was performed. The results are from three independent 
experiments (averages ± SD). (B) HeLa cells stably expressing ATP9A-HA were transfected with 
siRNAs against LacZ or ATP9A-1, and each cell lysate was analyzed by immunoblotting with 
anti-HA and anti-actin antibodies (as an internal control). (C) siRNA-treated HeLa cells described 
in A were stained for EEA1 (a), TfnR (b), Rab11 (c), Lamp-1 (d), or TGN46 (e). Cells were treated 
with Alexa Fluor 555–Tfn for 30 min at 37°C and then fixed (f). Scale bars: 20 μm. (D) siRNA-
treated HeLa cells described in A were lysed, and the lysates were analyzed by immunoblotting 
with anti-TfnR and anti-actin antibodies. (E) Fluorescence intensities of TfnR in (C, f–f″) were 
quantitated using the MetaMorph software; the frequency distribution of intensities is shown.
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MATERIALS AND METHODS
Plasmids
The entire coding sequence of human 
ATP9A was cloned into vector pENTR3C 
(Invitrogen, Carlsbad, CA) as described pre-
viously (Takatsu et al., 2011). The region en-
compassing the attR1 site, the ccdB gene, 
the chloramphenicol resistance gene, and 
the attR2 site (DEST) was amplified from 
pcDNA6.2/V5-DEST (Invitrogen). BglII and 
XhoI restriction sites were introduced at the 
5′ and 3′ ends of the DEST region and cloned 
into the pMXs-neo expression vector (Kita-
mura et al., 2003) with a C-terminal HA tag 
(pMXs-neo-DEST-HA). The pMXs-neo vector 
and pEF-gag-pol plasmid were kind gifts 
from Toshio Kitamura (University of Tokyo). 
Transfer of genes to pMXs-neo-DEST-HA 
was performed using the Gateway system 
(Invitrogen). The pCMV-VSVG-Rsv-Rev plas-
mid was a kind gift from Hiroyuki Miyoshi 
(RIKEN BRC). The pCAG-based vector for 
expression of ATP9A with a C-terminal HA 
tag was described previously (Takatsu et al., 
2011). The StxB expression vector was a kind 
gift from Ludger Johannes (Institut Curie; Jo-
hannes et al., 1997). A cDNA fragment of 
lactadherin C2 domain (LactC2) was pro-
vided by Hiroyuki Arai (University of Tokyo) 
and subcloned into the pEGFP vector 
(Clontech; Takatsu et al., 2013). The lentiviral 
vector pRRLsinPPT and packaging plas-
mids (pRSV-REV, pMD2.g, and pMDLg/
pRRE; Thomas et al., 2009) were kindly pro-
vided by Peter McPherson (McGill Univer-
sity). A fragment of EGFP-LactC2 was sub-
cloned into pRRLsinPPT.
Antibodies and reagents
Antibodies were obtained from the follow-
ing sources: monoclonal mouse anti-TfnR 
(H68.4) from Zymed (Carlsbad, CA); mono-
clonal mouse anti-EEA1 (clone 14), anti-
Rab11 (clone 47), anti-Lamp-1 (H4A3), anti-
p230 (Golgin-245), and anti-GM130 from 
BD Biosciences (San Diego, CA); monoclo-
nal rat anti-HA (3F10) from Roche Applied Science (Indianapolis, IN); 
polyclonal rabbit anti-GLUT1 from Abcam (Cambridge, UK); mono-
clonal mouse anti-StxB was purified from culture supernatant of a 
hybridoma clone (13C4) obtained from the American Type Culture 
Collection (Manassas, VA); Alexa Fluor–conjugated secondary anti-
bodies from Molecular Probes (Eugene, OR); Cy3-, DyLight649-, 
and horseradish peroxidase–conjugated secondary antibodies from 
Jackson ImmunoResearch Laboratories (West Grove, PA). Polyclonal 
rabbit anti-TGN46 (Kain et al., 1998) was a kind gift from Minoru 
Fukuda (Sanford-Burnham Medical Research Institute). Alexa Fluor–
conjugated Tfn and EGF were purchased from Molecular Probes. 
BFA was purchased from Sigma-Aldrich (St. Louis, MO).
RT-PCR and quantitative RT-PCR (RT-qPCR)
Total RNA was extracted from cells using the RNeasy kit (Qiagen) 
and subjected to RT-PCR analysis using the SuperScript III One-Step 
of ATP9A (Supplemental Figure S6), although the perinuclear 
signals of EGFP-LactC2 slightly increased as did those of TfnR in 
ATP9A-knockdown cells (Figure 5C). This could be explained in 
several ways: 1) ATP9A may have flippase activity toward other 
phospholipids but not PS; 2) even if ATP9A could flip PS and the 
local flippase activity of ATP9A is required for Tfn recycling, local 
changes of PS in the cytoplasmic leaflet of endosomes are unde-
tectable; or 3) expression of EGFP-LactC2, even at moderate lev-
els, may change PS dynamics by trapping cytoplasmic PS. Consis-
tent with this, overexpression of EGFP-LactC2 alters endosomal 
integrity.
ATP9A is localized to the TGN as well as to endosomes. It is 
therefore tempting to speculate that ATP9A plays a role in the for-
mation of transport carriers from the TGN in the secretory pathway. 
The substrate specificity of ATP9A and the roles of ATP9A at the 
TGN remain to be elucidated.
FIGURE 6: Depletion of ATP9A delays the recycling of Tfn. (A) HeLa cells were transfected with 
siRNAs against LacZ, ATP9A-1, or ATP9A-2; serum starved for 3 h; and then incubated at 4°C for 
60 min with Alexa Fluor 555–conjugated Tfn. Cells were washed and incubated at 37°C for the 
indicated times and then fixed and stained for TfnR. Scale bars: 20 μm. (B) Pixel intensities of 
Alexa Fluor 555–conjugated Tfn were estimated at the indicated times using MetaMorph 
software. Data are shown as the ratio of the mean of cellular Tfn intensities between cells 
depleted of ATP9A and control cells at each time point. The graph is representative of three 
independent experiments, and 160–200 cells of each sample were analyzed. Graphs show 
means ± SE. (C) HeLa cells were transfected with siRNAs as described above, incubated at 37°C 
for 60 min with Alexa Fluor 555–conjugated Tfn, washed, and subjected to time-lapse recording. 
Images in multiple areas were captured every 2 min for a total of 20 min, and pixel intensities of 
Alexa Fluor 555–Tfn were quantitated in every image. Graphs show means ± SE from 25 cells for 
siLacZ, 86 cells for siATP9A-1, and 59 cells for siATP9A-2. Raw data are shown in Supplemental 
Figure S2. (D) HeLa cells treated with siRNA against ATP9A-2 were serum starved for 3 h, 
incubated at 4°C for 60 min with Alexa Fluor 555–conjugated Tfn, washed, incubated at 37°C 
for 20 min, and stained with anti-EEA1, anti-TfnR, and anti-Lamp-1 antibodies, followed by 
anti-mouse Alexa Fluor 488–conjugated secondary antibody. Images were obtained by confocal 
microscopy. Scale bars: 20 μm.
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EGFP-LactC2 was transfected into HEK293T cells using Polyethyl-
enimine Max (Polysciences, Warminster, PA) along with the 
packaging plasmids (pRSV-REV, pMD2.g, and pMDLg/pRRE). The 
resultant lentiviruses were concentrated as described previously 
(Takatsu et al., 2013) and then used to infect HeLa cells to establish 
stable cells. The infected cells were selected in medium containing 
G418 (1 mg/ml). The HA-tagged ATP9A-expressing stable cell line 
was obtained by transfection with pcDNA3-ATP9A-HA and selec-
tion with G418 (1 mg/ml).
Knockdown of ATP9A was performed as described previously 
(Yamamoto et al., 2010; Kondo et al., 2012). Briefly, pools of siRNAs 
targeting the coding region of human ATP9A (PCR amplified 
RT-PCR system (Invitrogen). For RT-qPCR, total RNA was subjected 
to reverse transcription using a SuperScript VILO cDNA Synthesis 
Kit (Invitrogen). The resultant cDNA was used as a template for PCR 
using LightCycler FastStart DNA MasterPLUS SYBR Green I (Roche 
Applied Science). ATP8A1 and ATP9A fragments were amplified 
using the following primers: ATP8A1 forward, 5′-gaaacgctaat-
gaaagcagacatc-3′; ATP8A1 reverse, 5′-gtgttgaagtccagggcattc-3′; 
ATP9A forward, 5′-gcctcaccaagatcctctttgg-3′; ATP9A reverse, 
5′-ggttcacgcgcaaactaatggg-3′. ATP9A mRNA expression was nor-
malized against the level of β-actin mRNA in the same sample.
Cell culture and RNAi
HeLa cells were cultured in minimal essential medium supple-
mented with 10% heat-inactivated fetal bovine serum. pRRLsinPPT-
FIGURE 7: Depletion of ATP9A inhibits recycling of GLUT1. (A) HeLa 
cells were transfected with siRNAs against LacZ, ATP9A-1, or 
ATP9A-2, and then stained with anti-GLUT1 antibody. After being 
fixed, cells were incubated with Alexa Fluor–conjugated secondary 
antibody. Scale bar: 20 μm. (B) Cells in which GLUT1 localized to the 
plasma membrane (white), to the plasma membrane and endosomes 
(black), or to the endosomes (gray) in A were counted; counts were 
normalized against the total number of counted cells. A total of 214 
cells for siLacZ, 199 cells for siATP9A-1, and 180 cells for siATP9A-2 
were counted. (C) HeLa cells treated with siRNA against ATP9A-2 
were fixed, permeabilized, and incubated with anti-GLUT1 and 
anti-EEA1, anti-Vps35, anti-TfnR, or anti-Lamp-1 antibodies, followed 
by Alexa Fluor 555–conjugated anti-rabbit and Alexa Fluor 488–
conjugated anti-mouse secondary antibodies. Images were obtained 
by confocal microscopy. Scale bars: 20 μm. (D) Parental HeLa cells and 
two clones of ATP9A knockout cells were stained with anti-GLUT1 
antibody. After fixation, cells were incubated with Alexa Fluor–
conjugated secondary antibody. Scale bar: 20 μm.
FIGURE 8: Depletion of ATP9A does not affect EGF trafficking. 
(A) HeLa cells were transfected with siRNAs against LacZ, ATP9A-1, or 
ATP9A-2; serum starved for 3 h; incubated at 4°C for 60 min with 
Alexa Fluor 488–conjugated EGF; washed; and incubated at 37°C for 
the indicated times. Cells were fixed and stained for EEA1. Scale bars: 
20 μm. (B) Pixel intensity of Alexa Fluor 488–conjugated EGF was 
estimated at the indicated times using MetaMorph software. Data are 
shown as the ratio of the mean of cellular EGF intensities between 
cells depleted of ATP9A and control cells at each time point. Graph is 
representative of three independent experiments, and 100–200 cells 
of each sample were analyzed. Graphs show means ± SE.
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(pDonor-tBFP-NLS-Neo; deposited in Addgene, ID 80766) contain-
ing a insertion cassette for the single-guide RNA (sgRNA)-guided 
cleavage site and reporter genes (TagBFP-3×NLS [nuclear localiza-
tion signal] and neomycin resistance gene; referred to as Donor in 
this article; Supplemental Figure S3). Both plasmids were intro-
duced into HeLa cells by transfection using the X-tremeGENE9 
DNA Transfection Reagent (Roche). Transfected cells were selected 
in medium containing G418 (1 mg/ml), and clones were isolated on 
the basis of expression of the reporter gene Tag-BFP. For confirma-
tion of editing of ATP9A, genomic DNA was extracted from indi-
vidual clones, and subjected to PCR with three primer sets to am-
plify ATP9A lacking the Donor integration (GS1, 5′-tagggctgggatgt-
gattgtg-3′, and GAS1, 5′-ggccggcatcaggctaggtg-3′), ATP9A with 
Donor integrated in the forward orientation (D-primer, 5′-gttgtccac-
ggtgccctccatgtac-3′ and GS1), and ATP9A with Donor integrated in 
the reverse orientation (D-primer and GAS1). Among clones with 
Donor-integrated clones in either orientation, the knockout (KO) 
was confirmed by direct sequencing of the amplified PCR product, 
ATP9A without Donor integration, using a specific sequencing 
primer (GS2, 5′-gagctcgggcccatggtgc-3′) (Supplemental Figure S3). 
The ATP9A gene was observed in three of eight clones carrying bial-
lelic changes that resulted in Donor integration in forward and 
frame-shifting indels. Two of these clones (2 and 23) were used in 
this study.
Uptake of Tfn, EGF, and StxB; immunofluorescence; 
and time-lapse imaging analysis
Tfn internalization and recycling assays and EGF internalization as-
say were carried out as described previously (Shin et al., 2004; 
Kondo et al., 2012). HeLa cells were transfected with a pool of siR-
NAs targeting LacZ (as a control) or ATP9A. At 120 h posttransfec-
tion, cells were serum starved for 3 h in MEM medium containing 
0.2% bovine serum albumin and then incubated with Alexa Fluor 
488– or Alexa Fluor 555–conjugated Tfn or Alexa Fluor 488–
conjugated EGF (Molecular Probes) at 4°C for 60 min. After cells 
were washed with ice-cold PBS, they were incubated in medium 
containing unlabeled holo-Tfn or normal medium (for Tfn or EGF 
uptake, respectively) at 37°C for the indicated times and processed 
for immunofluorescence analysis (Shin et al., 2004). In some cases, 
serum-starved cells were incubated with Alexa Fluor 488– or Alexa 
Fluor 555–conjugated Tfn at 37°C for 30 min, washed, and then in-
cubated in medium containing unlabeled holo-Tfn at 37°C for the 
indicated times. For StxB uptake assay, cells were incubated with 
StxB (final concentration of 3.5 μg/ml) at 4°C for 60 min. After being 
washed, the cells were incubated in normal medium without StxB at 
37°C for the indicated times and then processed for immunofluores-
cence analysis with anti-StxB antibody (Man et al., 2011).
For detection of PS-positive compartments using recombinant 
EGFP-LactC2, cells were fixed with 3% paraformaldehyde (PFA) and 
permeabilized with 20 μM digitonin for 5 min at room temperature. 
After incubation with recombinant EGFP-LactC2 and indicated anti-
bodies, cells were fixed again with 3% PFA before mounting. Im-
munofluorescence analysis was performed on an Axiovert 200 MAT 
microscope (Carl Zeiss, Jena, Germany) for epifluorescence imaging 
or an A1R-MP (Nikon, Tokyo, Japan) or FV1000 (Olympus, Melville, 
NY) microscope for confocal imaging. The fluorescence intensity of 
Tfn was quantitated using MetaMorph imaging software (Molecular 
Devices, Sunnyvale, CA).
For time-lapse recording, siRNA-treated cells were allowed to 
internalize Alexa Fluor 555–conjugated Tfn for 30 min at 37°C, 
washed, placed on a microscope stage prewarmed to 37°C, and 
then observed on an A1R-MP confocal microscope. Images in 
using primers 5′-gaacttcaccatcctacagatc-3′ and 5′-ccacgccgcagt-
cagattcc-3′) or the 3′-untranslated region of human ATP9A (PCR 
amplified using primers 5′- ttggtggatctttaagagccaag-3′ and 
5′-aagtcaacttgtgcacctcaatc-3′) were prepared using the BLOCK-iT 
RNAi TOPO transcription kit and BLOCK-iT Dicer RNAi kit (Invitro-
gen) or the Replicator RNAi kit and PowerCut Dicer (Fynnzymes, 
Vantaa, Finland). Cells were transfected with siRNAs using Lipo-
fectamine 2000 (Invitrogen) and incubated for 24 h. The trans-
fected cells were then split and seeded onto culture dishes. After 
24 h, the cells were transfected again with the siRNAs and incu-
bated for 24 h. The transfected cells were then transferred to new 
culture dishes containing coverslips, incubated for another 48 h, 
and processed for immunofluorescence and immunoblot analyses 
as described previously (Shin et al., 2004; Ishizaki et al., 2008; 
Nakai et al., 2013).
Gene editing by CRISPR/Cas9
We inactivated the ATP9A gene in HeLa cells using the CRISPR/Cas 
(CRISPR-associated) 9 system (Cong et al., 2013; Ran et al., 2013). 
Target sequences for ATP9A gene were designed using the CRISPR 
Design Tool from the Zhang lab (http://crispr.mit.edu). Complemen-
tary oligonucleotides (5′-caccgttctggcgcaccggctgcag-3′ and 
5′-aaacctgcagccggtgcgccagaac-3′; target sequences are under-
lined) were synthesized and introduced into BbsI-digested vector 
PX459 (Addgene #48139). To edit the ATP9A gene, we used a pre-
viously described method (Kimura et al., 2014) with some modifica-
tions (unpublished data): cotransfection of the plasmid containing 
ATP9A target sequences and the Cas9 gene, and a donor plasmid 
FIGURE 9: Depletion of ATP9A does not affect StxB trafficking. 
(A) HeLa cells were transfected with siRNAs against LacZ, ATP9A-1, or 
ATP9A-2; incubated at 4°C for 60 min with anti-StxB antibody; 
washed; and incubated at 37°C for the indicated times. The cells were 
then fixed and stained for golgin-97, followed by Alexa Fluor 555–
conjugated anti-mouse and Alexa Fluor 488–conjugated anti-rabbit 
secondary antibodies. Scale bars: 20 μm. (B) Golgi arrival of 
internalized StxB was estimated by counting cells in which StxB 
colocalized with golgin-97. A total of 211 cells for siLacZ, 250 cells for 
siATP9A-1, and 241 cells for siATP9A-2 were counted.
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multiple areas were acquired every 2 min for a total of 20 min; each 
image was acquired for 2 s. The fluorescence intensity of Tfn was 
quantitated using the NIS Elements software (Nikon).
Preparation of recombinant EGFP-LactC2
EGFP-LactC2 C-terminally fused to glutathione S-transferase (GST) 
was expressed in Escherichia coli BL21-Codon Plus (DE3) cells 
(Stratagene, La Jolla, CA) and purified as described previously 
(Takatsu et al., 2013). Expression of fluorescent proteins was in-
duced by 0.1 mM isopropyl β-d-thiogalactopyranoside (Nacalai 
Tesque, Kyoto, Japan) at 20°C overnight. After purification with glu-
tathione–Sepharose 4B beads (GE Healthcare), GST-fusion proteins 
were cleaved using PreScission protease to elute fluorescent 
proteins.
Preparation of liposome and competition assay
PS- or PI-liposomes were prepared with cholesterol (10 mol%), PC 
(45 mol%), PE (35 mol%), and either PS (10 mol%) or phosphati-
dylinositol (PI; 10 mol%), respectively. PC-liposomes were prepared 
using PC instead of PS or PI. Each liposome was preincubated with 
recombinant EGFP-LactC2 (rEGFP-LactC2) for 1 h and then re-
moved by ultracentrifugation at 100,000 × g for 1 h. The superna-
tant was added to the fixed and permeabilized cells as described 
above.
Immunoblot analysis
Cells were lysed in lysis buffer (20 mM HEPES, pH 7.4, 150 mM 
NaCl, 1% Nonidet P-40, 1 mM EDTA) containing a protease inhibi-
tor mixture (Nacalai Tesque) at 4°C for 30 min. The lysates were 
centrifuged at maximum speed for 20 min at 4°C in a microcentri-
fuge to remove cellular debris and insoluble materials. Cell lysates 
(10 μg/sample) were incubated in SDS sample buffer containing β-
mercaptoethanol at 37°C for 2 h or at room temperature overnight, 
and then the samples were subjected to SDS–PAGE and immuno-
blot analysis using rat anti-HA, mouse anti-actin, or mouse anti-TfnR 
antibody. Immunoblots were developed using a Chemi-Lumi One L 
kit (Nacalai Tesque), and recorded on a LAS-3000 bioimaging sys-
tem (Fujifilm).
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